Innovative Eyewear officer plans $12.9K stock sale

Innovative Eyewear Inc (symbol LUCY) is the issuer for a notice of proposed sale of securities filed on behalf of officer David Eric Cohen under Rule 144.

Rhea-AI Filing Summary

Innovative Eyewear Inc (symbol LUCY) is the issuer for a notice of proposed sale of securities filed on behalf of officer David Eric Cohen under Rule 144. The notice covers a planned sale of up to 18,200 shares of common stock, expected on or about 08/19/2026, through Raymond James & Associates, Inc. The shares are described as originating from an RSU Grant by the issuer, with cash as the form of payment. The filing also reports that Cohen sold 1,860 shares of common stock on 07/06/2026 during the prior three months.

Key Figures

Shares proposed for sale: 18,200 shares of common stock Aggregate market value of proposed sale: $12,922.00 Shares sold in past 3 months: 1,860 shares of common stock +1 more

4 metrics

Shares proposed for sale 18,200 shares of common stock Proposed sale under Rule 144 expected on 08/19/2026

Aggregate market value of proposed sale $12,922.00 Value associated with 18,200 shares of common stock

Shares sold in past 3 months 1,860 shares of common stock Sale by David Cohen on 07/06/2026

Aggregate proceeds from prior sale $2,105.00 Proceeds from 1,860 shares sold on 07/06/2026

Key Terms

Rule 144, RSU Grant, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSU Grant financial

"Common | 08/19/2026 | RSU Grant | Issuer"

attorney-in-fact regulatory

"as attorney-in-fact for David Cohen"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144/A filing disclose for Innovative Eyewear Inc (LUCY)?

It discloses a planned sale under Rule 144 by officer David Eric Cohen of up to 18,200 shares of Innovative Eyewear Inc common stock, expected around 08/19/2026, and notes a prior sale of 1,860 shares on 07/06/2026.

How many LUCY shares are proposed to be sold under this Form 144/A?

The notice covers a proposed sale of up to 18,200 shares of Innovative Eyewear Inc common stock, with an expected sale date of 08/19/2026, to be executed through Raymond James & Associates, Inc..

What is the reported market value of the planned LUCY share sale?

The Form 144/A lists an aggregate market value of $12,922.00 for the planned sale of 18,200 shares of Innovative Eyewear Inc common stock as of the information provided in the filing.

What prior sales of Innovative Eyewear Inc (LUCY) shares are disclosed?

The filing reports that David Cohen sold 1,860 shares of Innovative Eyewear Inc common stock on 07/06/2026, with aggregate proceeds of $2,105.00, during the three months preceding the notice.

What is the source of the LUCY shares to be sold under this Form 144/A?

The common shares to be sold are described as coming from an RSU Grant by the issuer, Innovative Eyewear Inc, with the transaction structured for cash settlement and an expected sale date of 08/19/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 12:05 PM EDT Accepted by SEC EDGAR 08/24/2026 - 12:04 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001911813
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001974078-26-000317
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	Innovative Eyewear Inc
SEC File Number	001-41392
Address of Issuer	11900 BISCAYNE BLVD STE 630 MIAMI FLORIDA 33181
Phone	786-910-1898
Name of Person for Whose Account the Securities are To Be Sold	Cohen David Eric
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St. Petersburg FL 33716	18200	12922.00	6403728	08/19/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2026	RSU Grant	Issuer			18200	08/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Cohen 11900 Biscayne Blvd Suite 705630 Miami FL 33131	Common	07/06/2026	1860	2105.00

144/A: Remarks and Signature

Remarks
Date of Notice	08/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Melissa Fisher, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for David Cohen
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)